目的:为外科住院患者人血白蛋白临床合理使用提供参考。方法:分析某院外科2014年1-3月住院患者人血白蛋白的使用情况,并以美国大学医院联合会(UHC)制订的《人血白蛋白、非蛋白胶体及晶体溶液使用指南》(2010版)和欧洲《免疫球蛋白及白蛋白使用推荐》为标准进行评价。结果:556例患者共提交了895份人血白蛋白使用申请,主要集中在胃肠外科(29.7%)、肝胆外科(25.9%)和胸心外科(13.1%)。主要的用药理由为纠正低白蛋白血症(62.9%),其次是大手术期间的白蛋白补充(7.9%)和减轻肝硬化患者的腹水(4.4%);仅95份(10.6%)人血白蛋白申请理由符合指南适应证。最主要的不适宜用药理由为纠正低白蛋白血症。结论:该院外科住院患者人血白蛋白用量大,且其适应证与指南相符率低,需加强人血白蛋白的合理、规范使用。%OBJECTIVE:To provide reference for rational use of human serum albumin for surgical inpatients. METHODS:The utilization of human serum albumin for surgical inpatients in a hospital during Jan.-Mar. 2014 was analyzed and evaluated by UHC Guidelines for the Use of Album,Nonprotein Colloid,and Crystalloid Solutions(2010 edition)and European Immune Globu-lin and Albumin Use Recommendation. RESULTS:Among the 556 patients,totally 895 human serum albumin application were con-ducted,mainly involving development of gastrointestinal surgery(29.7%),hepatobiliary surgery(25.9%)and cardiothoracic sur-gery(13.1%). The main reasons were correcting hypoalbuminemia(62.9%),followed by albumin supplemented during major sur-gery(7.9%)and alleviating ascites in patients with cirrhosis(4.4%);only 95 applications(10.6%)were considered appropriate. The most prevalent inappropriate reason was for correcting hypoalbuminemia. CONCLUSIONS:Human serum albumin in the surgi-cal inpatients in the hospital shows a large amount,and low consistent rate between indications and guidelines. The rational stan-dardized utilization of human serum albumin should be strengthened.
展开▼